| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.19 | 0.5 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.5 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |